Screener
Ocular Therapeutix OCUL Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Interest expense | (2,777) | (2,984) |
| Change in fair value of derivative liabilities | 1,455 | (978) |
| Total other income (expense), net | 4,728 | (136) |
| Net loss | $(88,612) | $(64,053) |
| Net loss per share, basic | $(0.40) | $(0.38) |
| Weighted average common shares outstanding, basic | 224,099,410 | 169,396,989 |
| Net loss per share, diluted | $(0.40) | $(0.38) |
| Weighted average common shares outstanding, diluted | 224,099,410 | 169,396,989 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's net income?
- Ocular Therapeutix (OCUL) reported net income of -$88.61M in Q1 2026.
- How has Ocular Therapeutix's net income changed year-over-year?
- Ocular Therapeutix's net income decreased by 38.3% year-over-year, from -$64.05M to -$88.61M.
- What is the long-term trend for Ocular Therapeutix's net income?
- Over 4 years (2021 to 2025), Ocular Therapeutix's net income has grown at a 152.4% compound annual growth rate (CAGR), from -$6.55M to -$265.94M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Ocular Therapeutix's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude